Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,216JPY
5:11am BST
Change (% chg)

¥22 (+1.84%)
Prev Close
¥1,194
Open
¥1,198
Day's High
¥1,218
Day's Low
¥1,196
Volume
55,800
Avg. Vol
120,914
52-wk High
¥1,786
52-wk Low
¥1,099

Latest Key Developments (Source: Significant Developments)

Seikagaku says clinical trial for SI-449
Monday, 21 May 2018 

May 21 (Reuters) - Seikagaku Corp <4548.T>:Says it will initiate a clinical trial (pilot study) in Japan for SI-449, an adhesion barrier for use in surgery .  Full Article

Seikagaku announces new drug application approval of hernicore® 1.25 units for intradiscal injection in Japan
Friday, 23 Mar 2018 

March 23(Reuters) - Seikagaku Corp <4548.T>:Says it announced that the Japanese Ministry of Health, Labour and Welfare has approved the new drug application of HERNICORE® 1.25 units for intradiscal injection in Japan, indicated for the treatment of lumbar disc herniation.  Full Article

Ribomic signs collaborative research contract with SEIKAGAKU
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Ribomic Inc <4591.T>:Says it signed collaborative research contract with SEIKAGAKU CORPORATION <<<4548.T>>>.Says two entities mainly cooperate on new technologies development of drug discovery related to Aptamers.  Full Article

Seikagaku initiates phase II study of SI-613 for treatment of knee osteoarthritis in U.S.
Friday, 16 Jun 2017 

June 16(Reuters) - Seikagaku Corp <4548.T>:Says it announces the start of phase II study of SI-613 in patients with osteoarthritis of the knee, in the U.S. .  Full Article